Parkman Healthcare Partners’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-100,734
| Closed | -$4.07M | – | 101 |
|
|
2023
Q4 | $4.07M | Buy |
100,734
+734
| +0.7% | +$29.6K | 0.57% | 55 |
|
|
2023
Q3 | $2.64M | Buy |
+100,000
| New | +$2.64M | 0.48% | 61 |
|
|
2021
Q4 | – | Sell |
-57,978
| Closed | -$2.72M | – | 85 |
|
|
2021
Q3 | $2.72M | Hold |
57,978
| – | – | 0.69% | 45 |
|
|
2021
Q2 | $3.53M | Sell |
57,978
-7,196
| -11% | -$439K | 0.77% | 42 |
|
|
2021
Q1 | $4.02M | Sell |
65,174
-10,969
| -14% | -$676K | 0.93% | 34 |
|
|
2020
Q4 | $5.42M | Buy |
76,143
+915
| +1% | +$65.1K | 1.39% | 30 |
|
|
2020
Q3 | $2.82M | Buy |
75,228
+13
| +0% | +$488 | 0.75% | 47 |
|
|
2020
Q2 | $2.45M | Hold |
75,215
| – | – | 0.69% | 48 |
|
|
2020
Q1 | $2.18M | Buy |
+75,215
| New | +$2.18M | 1.01% | 33 |
|